Form D · Biotechnology
BIOMEDIX VASCULAR SOLUTIONS INC
St Paul, MN · CIK 0001385898
Offering snapshot reported Nov 23, 2012 · SEC filing
- Reported sold
- $682K Offering amount: $1.5M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 7, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 23, 2012 | Initial | $682,236 | No comparison | 26 | SEC filing |
| Jan 3, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-187398
Convertible Subordinated Promissory Notes
Source: Form D, filed Nov 23, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Reeders | Director |
| John Romans | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
178 East 9 Th Street
St Paul, MN, 55101
St Paul, MN, 55101